Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Baxter International Inc., commonly referred to as Baxter, is a leading player in the surgical and medical instrument manufacturing industry, headquartered in the United States. Founded in 1931, the company has established a strong presence in key operational regions, including North America, Europe, and Asia, focusing on innovative solutions for patients and healthcare providers.
Baxter's core offerings encompass a wide range of products, including intravenous (IV) solutions, renal care devices, and surgical instruments, distinguished by their commitment to quality and patient safety. The company has achieved notable milestones, such as pioneering advancements in renal therapies and infusion systems, solidifying its market position as a trusted provider in the healthcare sector. With a legacy of innovation and a dedication to improving patient outcomes, Baxter continues to lead the way in medical technology.
+35 vs industry average
Baxter’s score of 63 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Surgical and Medical Instrument Manufacturing has below-average carbon intensity
The Surgical and Medical Instrument Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Baxter's Climate Commitments and Emissions Performance
Baxter, a prominent player in the Surgical and Medical Instrument Manufacturing industry, headquartered in the US, is actively engaged in reducing its environmental impact. The company has set ambitious targets to achieve carbon neutrality and decrease greenhouse gas (GHG) emissions across its operations.
Latest Emissions Data:
In 2024, Baxter reported total global GHG emissions of approximately 4.3 billion kg CO2e. This figure encompasses:
In 2023, Baxter's total global emissions were approximately 4.1 billion kg CO2e. This included Scope 1 emissions of approximately 359 million kg CO2e and Scope 2 emissions (market-based) of approximately 220 million kg CO2e. Scope 3 emissions totalled approximately 3.5 billion kg CO2e.
Key Climate Commitments and Reduction Targets:
Baxter has established several key climate commitments:
Historical Emissions Trend:
Baxter has been reporting its emissions data for several years. In 2022, total global emissions were approximately 4.4 billion kg CO2e. Prior to that, in 2021, total emissions were approximately 3.8 billion kg CO2e, and in 2020, they stood at approximately 6.1 billion kg CO2e. Earlier reporting from 2019 showed total emissions of approximately 5.6 billion kg CO2e, and in 2018, approximately 5.2 billion kg CO2e. Baxter has demonstrated a commitment to reducing emissions intensity relative to revenue over the long term, with a historical target to reduce GHG emissions by 45% indexed to revenue by 2015 from a 2005 baseline. The company exceeded its 2010 target for a 20% reduction indexed to revenue, achieving a 29% reduction.
Access structured emission data, company specific factors and auditable source documents
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more